Relationship between the environmental endocrine disruptor bisphenol A and dyslipidemia: a five-year prospective study
R Li, S Yang, R Gao, Y Deng, J Liu, C Yuan, Q Yao… - Endocrine Practice, 2020 - Elsevier
Objective: To investigate whether serum bisphenol A (BPA) concentration is related to the
occurrence of dyslipidemia. Methods: A total of 574 adults were enrolled at baseline and
followed up for 5 years. Concentrations of serum BPA, triglycerides (TGs), low-density
lipoprotein (LDL) cholesterol, and high-density lipoprotein (HDL) cholesterol were
measured. Dyslipidemia was defined as the existence of one or more of the following
conditions: high-LDL-cholesterolemia (LDL≥ 140 mg/dL), hypertriglyceridemia (TGs≥ 150 …
occurrence of dyslipidemia. Methods: A total of 574 adults were enrolled at baseline and
followed up for 5 years. Concentrations of serum BPA, triglycerides (TGs), low-density
lipoprotein (LDL) cholesterol, and high-density lipoprotein (HDL) cholesterol were
measured. Dyslipidemia was defined as the existence of one or more of the following
conditions: high-LDL-cholesterolemia (LDL≥ 140 mg/dL), hypertriglyceridemia (TGs≥ 150 …
[PDF][PDF] RELATIONSHIP BETWEEN THE ENVIRONMENTAL ENDOCRINE DISRUPTOR BISPHENOL A AND DYSLIPIDEMIA: A FIVE-YEAR PROSPECTIVE STUDY
MD Ruolin Li, RG PhD23, MD Yin Deng… - 2019 - library.dphen1.com
… In our study, we not only explored the association between BPA exposure and HDL-c, TG …
We first demonstrated the effect of BPA on blood lipid changes during a five-year follow- …
confirmed association between dyslipidemia and cardiovascular disease (CVD), but our study …
We first demonstrated the effect of BPA on blood lipid changes during a five-year follow- …
confirmed association between dyslipidemia and cardiovascular disease (CVD), but our study …
以上显示的是最相近的搜索结果。 查看全部搜索结果